Press Releases

GlobeNewswire, Inc.

- Written FDA recommendations include a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for schizophrenia – - Current data package highlights well-tolerated long-term safety profile,...

GlobeNewswire, Inc.

Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses Recommendation based on the HERCULES phase 3 study which demonstrated that brain-penetrant Cenrifki...

Government of Timor-Leste

Spokesperson of the Government of Timor-Leste Ninth Constitutional Government ............................................................................................................................. Press Release Meeting of the Council of...

EIN Presswire

Awards Ceremony represents a "full circle" moment; the 35th Anniversary Gala will be held in Ponta Delgada, Azores WASHINGTON, DC, UNITED STATES, May 4, 2026 /⁨EINPresswire.com⁩/ -- The Portuguese-American Leadership Council of the United States...

Government of Timor-Leste

Spokesperson of the Government of Timor-Leste Ninth Constitutional Government ............................................................................................................................. Press Release Meeting of the Council of...

Government of Timor-Leste

Spokesperson of the Government of Timor-Leste Ninth Constitutional Government ............................................................................................................................. Press Release Extraordinary Meeting of the...

Government of Timor-Leste

Spokesperson of the Government of Timor-Leste Ninth Constitutional Government ............................................................................................................................. Press Release Meeting of the Council of...

GlobeNewswire, Inc.

- Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well tolerated using a steroid-only prophylactic immunomodulation regimen - - Duchenne: First participant...

GlobeNewswire, Inc.

NORCROSS, Ga., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension, today announced that it will host a...

EIN Presswire

NEW YORK, NY, UNITED STATES, January 30, 2026 /⁨EINPresswire.com⁩/ -- Creative Bioarray, one of the leading providers of innovative biological research tools and services, is always dedicated to accelerating research in the areas of life science...

GlobeNewswire, Inc.

SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced the appointment of Dr. Arumugham...

Government of Timor-Leste

Fri. 13 of March of 2026, 09:43h On March 2nd, 2026, during a regular plenary session, the National Parliament unanimously approved Law Proposal No. 19/VI (2nd) – Competition Law, with 60 votes in favour, no votes against, and no abstentions.

GlobeNewswire, Inc.

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 program using the higher clinical response level of HS...

Government of Timor-Leste

Spokesperson of the Government of Timor-Leste Ninth Constitutional Government ............................................................................................................................. Press Release 9th Government: Commitment to...

Government of Timor-Leste

Tue. 24 of February of 2026, 11:23h The Minister of National Liberation Combatants Affairs, Gil da Costa Monteiro “Oan Soru,” participated today, February 24th, 2026, in the recording of a new episode of the “Government Page” TV show, dedicated to...

MENAFN

(MENAFN) The World Health Organization (WHO) announced Thursday that expanded deployment of breakthrough malaria interventions—including dual-ingredient nets and WHO-recommended vaccines—averted an estimated 170 million cases and 1 million deaths...

MENAFN

(MENAFN) The World Health Organization (WHO) announced on Thursday that the expanded deployment of innovative malaria interventions—including dual-ingredient mosquito nets and WHO-endorsed vaccines—helped avert an estimated 170 million cases and 1...

GlobeNewswire, Inc.

SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim Labs”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced it has signed JCBio as an...

Macao Government News

MACAU, February 23 - Macao Polytechnic University’s (MPU) international development project, MPU Connect, has been shortlisted for the Times Higher Education (THE) Awards Asia 2026 in the category of International Strategy of the Year. This...

MENAFN

(MENAFN) The World Health Organization (WHO) announced on Thursday that the expanded deployment of innovative malaria interventions—including dual-ingredient mosquito nets and WHO-endorsed vaccines—helped avert an estimated 170 million cases and 1...